NCT00005888

Brief Summary

OBJECTIVES: I. Compare the incidence of late onset sepsis and/or necrotizing enterocolitis and duration of hospitalization in low birth weight infants fed with fortified mother's milk supplemented with either fortified pasteurized donor human milk or preterm formula, and with fortified mother's milk versus preterm formula. II. Determine the relationship between functional antibody titers in serial milk samples and the incidence of pathogen specific late onset sepsis (e.g., Staphylococcus epidermidis, Staphylococcus aureus) in these patients. III. Determine the long term sequelae (growth, body composition, health, and neurodevelopment) of human milk versus formula feeding in these patients. IV. Determine the relationship between stress and milk production in the mothers of these patients.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1997

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

June 2, 2000

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 5, 2000

Completed
Last Updated

June 24, 2005

Status Verified

April 1, 2002

First QC Date

June 2, 2000

Last Update Submit

June 23, 2005

Conditions

Keywords

gastrointestinal disordersimmunologic disorders and infectious disorderslow birth weightnecrotizing enterocolitisneonatal disordersrare diseasesepsis

Interventions

Eligibility Criteria

Age0 Years - 96 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
* Infants of less than 30 weeks gestational age * Less than 96 hours after birth * No HIV positive mothers who plan to nurse * No major congenital malformations

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Baylor College of Medicine

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Enterocolitis, NecrotizingSepsisGastrointestinal DiseasesImmune System DiseasesCommunicable DiseasesInfant, Newborn, DiseasesRare Diseases

Condition Hierarchy (Ancestors)

EnterocolitisGastroenteritisDigestive System DiseasesIntestinal DiseasesInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsDisease AttributesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Richard J. Schanler

    Baylor College of Medicine

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Sponsor Type
NIH

Study Record Dates

First Submitted

June 2, 2000

First Posted

June 5, 2000

Study Start

January 1, 1997

Last Updated

June 24, 2005

Record last verified: 2002-04

Locations